SDZ-217-766

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSDZ-217-766
Drug Alias NameSDZ-217-766
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine protease inhibitorsFactor IIa inhibitors
TargetsSerine proteaseProthrombin
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSandoz Ltd
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A